Samer Renno practices Hematology. He received 1 awards: "Meaningful Use Stage 1 Certification". Samer Renno is a published physician as well. He has 2 publications published. The latest was: Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Doctor Samer I. Renno, MD accepts Medicare.
NPI NUMBER | 1588758312 | |
NPPES Provider LastName | RENNO | |
NPPES Provider FirstName | SAMER | |
NPPES Provider ZIPCode | 681221709 | |
NPPES Provider State | NE | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 756.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 78.0 | |
Percent Opioid Claims | 10.32 |
National Provider Identifier [NPI] | 1588758312 |
Last Name Of The Provider | RENNO |
First Name Of The Provider | SAMER |
View All |
Dr. Donald B. Wender, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Inaganti M. Shah, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Henry T. Lynch, MD | |
Dr. Joseph D. Verdirame, MD |